J. Goldman & Co’s Boston Scientific BSX Stock Holding History

J. Goldman & Co’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$555K	Sell	13,000 -31,485	-71%	-$1.71M	0.01%	544
2026 Q1	$2.79M	Buy	+44,485	New	+$3.56M	0.08%	269
2024 Q2	–	Sell	-22,440	Closed	-$1.54M	–	457
2024 Q1	$1.54M	Sell	22,440 -7,573	-25%	-$487K	0.05%	238
2023 Q4	$1.74M	Buy	30,013 +14,485	+93%	+$773K	0.07%	197
2023 Q3	$820K	Buy	+15,528	New	+$814K	0.03%	246
2020 Q2	–	Sell	-107,514	Closed	-$3.51M	–	266
2020 Q1	$3.51M	Sell	107,514 -61,726	-36%	-$2.41M	0.42%	66
2019 Q4	$7.65M	Buy	169,240 +34,664	+26%	+$1.45M	0.55%	56
2019 Q3	$5.48M	Sell	134,576 -17,066	-11%	-$723K	0.41%	80
2019 Q2	$6.52M	Sell	151,642 -273,210	-64%	-$10.5M	0.45%	78
2019 Q1	$16.3M	Buy	424,852 +271,971	+178%	+$10.4M	0.92%	24
2018 Q4	$5.4M	Buy	+152,881	New	+$5.54M	0.42%	72
2016 Q4	–	Sell	-18,800	Closed	-$447K	–	303
2016 Q3	$447K	Buy	+18,800	New	+$448K	0.03%	266
2013 Q4	–	Sell	-88,000	Closed	-$1.03M	–	226
2013 Q3	$1.03M	Buy	+88,000	New	+$952K	0.1%	194

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

J. Goldman & Co's BSX Position: Q2 2026 in Review

J. Goldman & Co reduced its Boston Scientific (BSX) stake by 71% in Q2 2026, selling an estimated $1.71M and leaving 13,000 shares worth $555K. The position accounts for 0.01% of the portfolio, ranked #544.

J. Goldman & Co first reported a position in BSX in Q3 2013 and has held it in 13 quarters since. The position peaked at $16.3M in Q1 2019. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

J. Goldman & Co held 13,000 shares of Boston Scientific worth $555K as of Q2 2026.
J. Goldman & Co sold 31,485 Boston Scientific shares in Q2 2026, an estimated $1.71M.
Boston Scientific made up 0.01% of J. Goldman & Co's portfolio in Q2 2026, its #544 holding.
J. Goldman & Co first reported a position in Boston Scientific in Q3 2013 and has held it in 13 quarters since.
J. Goldman & Co's Boston Scientific position peaked at $16.3M in Q1 2019.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on J. Goldman & Co's 13F filing for Q2 2026, filed 14 Aug 2026.